Phospholipase C is a novel class of phosphoinositide-specific phospholipase C, identified as a downstream effector of Ras and Rap small GTPases. We report here the first genetic analysis of its physiological function with mice whose phospholipase C is catalytically inactivated by gene targeting. The hearts of mice homozygous for the targeted allele develop congenital malformations of both the aortic and pulmonary valves, which cause a moderate to severe degree of regurgitation with mild stenosis and result in ventricular dilation. The malformation involves marked thickening of the valve leaflets, which seems to be caused by a defect in valve remodeling at the late stages of semilunar valvulogenesis. This phenotype has a remarkable resemblance to that of mice carrying an attenuated epidermal growth factor receptor or deficient in heparin-binding epidermal growth factor-like growth factor. Smad1/5/8, which is implicated in proliferation of the valve cells downstream of bone morphogenetic protein, shows aberrant activation at the margin of the developing semilunar valve tissues in embryos deficient in phospholipase C. These results suggest a crucial role of phospholipase C downstream of the epidermal growth factor receptor in controlling semilunar valvulogenesis through inhibition of bone morphogenetic protein signaling.
Phospholipase C is a novel class of phosphoinositide-specific phospholipase C, identified as a downstream effector of Ras and Rap small GTPases. We report here the first genetic analysis of its physiological function with mice whose phospholipase C is catalytically inactivated by gene targeting. The hearts of mice homozygous for the targeted allele develop congenital malformations of both the aortic and pulmonary valves, which cause a moderate to severe degree of regurgitation with mild stenosis and result in ventricular dilation. The malformation involves marked thickening of the valve leaflets, which seems to be caused by a defect in valve remodeling at the late stages of semilunar valvulogenesis. This phenotype has a remarkable resemblance to that of mice carrying an attenuated epidermal growth factor receptor or deficient in heparin-binding epidermal growth factor-like growth factor. Smad1/5/8, which is implicated in proliferation of the valve cells downstream of bone morphogenetic protein, shows aberrant activation at the margin of the developing semilunar valve tissues in embryos deficient in phospholipase C. These results suggest a crucial role of phospholipase C downstream of the epidermal growth factor receptor in controlling semilunar valvulogenesis through inhibition of bone morphogenetic protein signaling.
The hydrolysis of phosphatidylinositol 4,5-bisphosphate (PIP 2 ) by phosphoinositide-specific phospholipase C (PLC) is a key event triggering intracellular signal transduction from various receptor molecules at the plasma membrane by yielding two intracellular second messengers, diacylglycerol and inositol 1,4,5-trisphosphate, which induce activation of protein kinase C and mobilization of Ca 2ϩ from intracellular stores, respectively (9) . Concurrently, reduction in PIP 2 concentration appears to be an important signal because activities of various actin-binding proteins and pleckstrin homology domain-containing proteins are modulated through interaction with PIP 2 (25) . More than 12 mammalian PLC isoforms have been identified and organized into five classes (␤, ␥, ␦, ε, and ), which are regulated through distinct mechanisms (9) . PLCε is characterized by possession of two Ras-associating domains and a CDC25 homology domain. The Ras-associating domains are responsible for activation of PLCε through direct association with the GTP-bound active forms of the small GTPases Ras (15, 23) , Rap1 (23, 24) , and Rap2 (20) . Stimulation of cells by growth factors, such as platelet-derived growth factor, induces persistent activation of PLCε through activation of Ras and Rap1 (24) . The rapid and initial phase of this activation is mediated by Ras at the plasma membrane, whereas Rap1 is responsible for the prolonged activation mainly at the Golgi complex (24) . The CDC25 homology domain acts as a guanine nucleotide exchange factor for Rap1 and is crucial for the prolonged activation of PLCε by Rap1 (14, 24) . The involvement of other factors, such as the ␣ subunits of the G 12 and G 13 families or the ␤ 1 ␥ 2 subunits of heterotrimeric G proteins (18, 29) and Rho small GTPase (30) , in regulation of PLCε was also reported, but their underlying mechanisms still remain unclear. Although the molecular mechanism of PLCε regulation has been intensively studied, little is known about its physiological function. Because multiple isoforms of PLCs are usually expressed in a single cell, functional analysis of an individual isoform needs a targeted disruption of the corresponding gene. These analyses with ␤ and ␦ isoforms have been successful in elucidating their distinct and cell-type-specific roles (9) . In this paper, we show that PLCε is required for proper formation of the semilunar valves by generation and phenotypic characterization of mice whose PLCε is genetically inactivated. exons encoding the X domain was replaced with an inverted PGK-neo cassette for positive selection, in which expression of the neomycin-resistance gene is driven by the phosphoglycerate kinase promoter (Fig. 1A) . The targeting vector also possessed the diphtheria toxin A chain cassette for negative selection. Gene targeting and generation of mutant mice. To generate the targeted PLCε allele, designated PLCε ⌬X , mouse embryonic stem (ES) cells derived from 129/Sv strain were transfected with the linearized targeting vector by electroporation and subsequently subjected to selection with G418. The G418-resistant clones were isolated and screened by Southern blot analysis of their EcoRVcleaved genomic DNAs with the probes depicted in Fig. 1A . Out of more than 1,000 clones analyzed, only 1 ES clone carried the properly generated PLCε ⌬X allele and was injected into mouse C57BL/6 blastocysts to generate a chimeric male, which was subsequently bred with C57BL/6 females to generate heterozygous mice. Homozygous mutant mice were generated by cross-breeding of heterozygous mice. Mice were maintained on a hybrid of 129/Sv and C57BL/6, and their genotypes were determined within 3 weeks after birth by PCR with allelespecific primers (5Ј-CATGTGTCATCAAGGCCTAC-3Ј and 5Ј-CTATAGAGC TCCACAGAGGACTC-3Ј for the wild-type allele; 5Ј-GAATGTGTGCGAGG CCGAAGG-3Ј and 5Ј-GCTATGTAAGCCTGGAATTGCATC-3Ј for the targeted allele). To obtain PLCε ⌬X/⌬X embryos, female PLCε ⌬X/ϩ mice were placed together with a male PLCε ⌬X/ϩ mouse overnight. The next noon was defined as embryonic day 0.5 (E0.5). The genotypes of embryos were determined similarly by PCR with genomic DNA isolated from their extraembryonic membranes. All animals were maintained at the animal facilities of Kobe University Graduate School of Medicine according to institutional guidelines.
MATERIALS AND METHODS

Construction
Reverse transcription (RT)-PCR analysis. Total cellular RNA was prepared from mouse hearts with TRIzol reagent (Invitrogen), and the first-strand oligo(dT)-primed cDNA was synthesized as previously described (31) . Primers used for amplification of PLCε were 5Ј-TCAGTGCCTGGAGCAGCAG-3Ј and 5Ј-C TTGAAGGGGATCTTGGTTG-3Ј, and those for ␤-actin were described previously (31) .
Western blot analyses. Protein was extracted from the cerebellum of adult mice with lysis buffer (50 mM Tris-HCl [pH 7.4], 200 mM NaCl, 1% [vol/vol] NP-40, 1.5 g of leupeptin/ml, 1.5 g of aprotinin/ml). Protein concentrations were determined by the Bradford method (Bio-Rad). Western blotting with the anti-mouse PLCε antibody was performed as described previously (31) .
In vitro PLC assay. Fragments of mouse PLCε consisting of its X, Y, and C2 domains (amino acids 1280 to 1943 for the wild type and amino acids 1280 to 1332 and 1409 to 1943 for the deletion mutant) were expressed as fusions with Schistosoma japonicum glutathione S-transferase (GST) in Escherichia coli BL21(DE3) by using pGEX6P-1 (Amersham Biosciences) and purified with glutathione-Sepharose resin (Amersham Biosciences). Full-length rat PLC␦1 (PLC␦1) was also produced and purified as a GST fusion protein (22) . Their PIP 2 -hydrolyzing activities were determined as described previously (22) .
Histochemistry. Newborn mice and embryos were fixed in 10% formalin in phosphate-buffered saline at 4°C overnight. For histological analyses of tissues of adult mice, paraffin-embedded sections were prepared and stained with hematoxylin and eosin (H&E). For examination of fibrosis of the heart, azan staining was performed on paraffin-embedded 5-m-thick transverse serial sections. To analyze the hearts of embryos, standard H&E staining was performed on 6-mthick serial transverse cryosections. The thickness of the semilunar valves was measured on two or three leaflets per each valve of individual embryos and averaged. The size of semilunar valve cells was calculated by dividing the area of the valve leaflet by the number of nuclei stained with H&E, both of which were determined with a digital microscope (VH-8000; Keyence, Osaka, Japan). For immunohistochemical analyses with confocal laser microscopes (LSM510 META; Zeiss, Jena, Germany), cryosections were pretreated with 10 g of proteinase K /ml of phosphate-buffered saline containing 0.1% Triton X-100 for 15 min, followed by blocking with 1% bovine serum albumin for 1 h. The sections were then treated with a primary antibody specific to PLCε (31) RB-081A0; Neo Markers) at 4°C overnight and subsequently treated with Alexa Fluor 488-labeled anti-rabbit immunoglobulin G and/or Alexa Fluor 546-labeled anti-mouse immunoglobulin G (Molecular Probes, Inc.) or with fluoresceinlabeled anti-rabbit immunoglobulin G (Chemicon) and Alexa Fluor 546-labeled anti-goat immunoglobulin G for 1 h. A TdT-mediated dUTP nick end labeling assay was performed on proteinase K-treated cryosections with an in situ cell death detection kit (Roche Diagnostics Corp.). Nuclear staining with 4Ј6-diamino-5-phenylindole (DAPI) was carried out as previously described (31) .
Echocardiographic analysis. Mice were anesthetized with Avertin administered intraperitoneally at 250 g/g of body weight. Transthoracic echocardiography was performed with a Toshiba Aplio instrument along with a 14-MHz linear transducer (PLT-1202S; Toshiba). Left ventricular internal dimension at end-diastole and end-systole (LVIDd and LVIDs, respectively), interventricular septal thickness at end-diastole, and left ventricular posterior wall thickness at end-diastole were measured on M-mode images. The percent fractional shortening (% FS) and heart rate-corrected mean velocity of circumferential fiber shortening (mVcfc) were calculated as % FS ϭ 100 ϫ (LVIDd Ϫ LVIDs)/LVIDd and mVcfc ϭ % FS ϫ (cycle length) 1/2 /duration of aortic valve opening. Velocities of aortic outflow and diastolic transmitral left ventricular inflow were measured from angulated parasternal long-axis views obtained by a 6.6-MHz pulsed-wave Doppler transducer with a sample volume length of 1.0 mm. To measure the velocity of aortic or pulmonary flow, the sample volume was fixed about 1 mm above the semilunar valves as a guide of color flow-mapping Doppler. Attempts were made to align the ultrasound beam as parallel as possible to flow and to record the highest velocities.
In vivo hemodynamic study. Mice were anesthetized with Avertin (250 g/g), and their trachea and right carotid artery were exposed. Mice were then intubated with a blunt 21-gauge-needle tube and connected to a volume-cycled rodent ventilator (SN-480-7; SHINANO) with a tidal volume of 0.2 ml and a respiratory rate of 100 beats/min. A 1.4-F microtip catheter (SPR671; Millar Instruments) was inserted retrograde into the left ventricle through the right carotid artery. Data were collected with an analog-to-digital converter (Power Laboratory; ADInstruments) and recorded (Chart, version 4; ADInstruments) in real time. The maximal pressure gradient between the maximal systolic pressure of the left ventricle and that of the aorta was measured by pulling the catheter back from the left ventricle to the aorta and averaged from three to five consecutive beats of left ventricle and aortic pressures.
Statistical analysis. Values are expressed as means Ϯ standard error. The unpaired Student t test with Welch correction was performed to determine P values with GraphPad InStat software (GraphPad Software, Inc.). If P values were Ͻ0.05, differences were considered to be statistically significant.
RESULTS
Generation of PLC
⌬X/⌬X mice. We generated a targeted PLCε allele, designated PLCε ⌬X , by replacing the 3Ј part of one of four exons encoding the X domain with the PGK-neo cassette in mouse 129/Sv-derived ES cells. Out of more than 1,000 G418-resistant ES clones, only one clone carried the properly targeted PLCε allele and was used for the generation of mutant mice (data not shown). Hybridization of the EcoRV- 1A and B) . Hybridization of the same DNAs with a PGK-neo cassette-specific probe (neo probe) identified only a 5.2-kb band in PLCε ⌬X/⌬X and PLCε ⌬X/ϩ mice, indicating the absence of an extracopy integration of the PGK-neo cassette (Fig.  1A and B) . The PLCε ⌬X allele was also verified by PCR. Targeted allele-specific primers amplified a 270-bp product of the predicted size from PLCε ⌬X/⌬X and PLCε ⌬X/ϩ mouse genomic DNA (Fig. 1A and C) . RT-PCR analysis of the heart mRNA revealed the existence of a shortened PLCε mRNA in PLCε ⌬X/⌬X and PLCε ⌬X/ϩ mice (Fig. 1D) . Sequence determination of the 676-bp PCR product amplified from the transcript of the PLCε ⌬X allele revealed deletion of another upstream exon, which was presumably caused by exon skipping upon RNA splicing (Fig. 1D) . This resulted in production of a PLCε mutant carrying an in-frame deletion of amino acids 1333 to 1408, as illustrated in Fig. 1E . Western blot analysis of cell extracts of the PLCε ⌬X/⌬X and PLCε ⌬X/ϩ mouse cerebella with the anti-PLCε antibody recognizing its C terminus revealed residual expression of the mutant PLCε (PLCε⌬X) in the mutant mice (Fig. 1F) . The deletion encompasses the Nterminal part of the X domain, which contains essential residues for the enzymatic activity of PLC (5, 7, 8) . In fact, the specific activities of the wild-type and mutant proteins were determined to be 51 and 0.76 nmol/min/mg of protein, respectively, by an in vitro assay employing their recombinant GST fusion polypeptides consisting of the X, Y, and C2 domains, demonstrating that this deletion completely abrogated PIP 2 -hydrolyzing activity (Fig. 1G) .
Ventricular dilation in PLC ⌬X/⌬X mice. Expression of PLCε mRNA was detected at various levels in almost all the tissues in mammals (15, 18, 31) . We had shown by in situ hybridization analyses that PLCε is highly expressed in developing neural tissues and skeletal muscle tissues in mouse embryos (31) and by immunohistochemical analyses that PLCε is highly expressed in neurons in the brain and modestly in the skin, skeletal muscles, and heart of adult mice (1, 31; data not shown). Therefore, we expected that inactivation of PLCε might result in defects of these organs. However, PLCε ⌬X/⌬X pups were born at normal Mendelian ratios (PLCε ϩ/ϩ : PLCε ⌬X/ϩ :PLCε ⌬X/⌬X ϭ 26.4%:49.4%:24.2%; 632 pups) without any intrauterine loss or early death; the pups were fertile and indistinguishable from their PLCε ϩ/ϩ or PLCε ⌬X/ϩ littermates in appearance and growth (data not shown). They grew normally for at least 2 years. However, anatomical examination revealed that their hearts were enlarged compared with those of PLCε ϩ/ϩ and PLCε ⌬X/ϩ mice ( Fig. 2A and B) , while other organs, including neuronal tissues that express PLCε at a high level (31) , appeared anatomically and histologically normal (data not shown). The heart-to-body weight ratio of PLCε ⌬X/⌬X mice was greater than those of PLCε ϩ/ϩ and PLCε ⌬X/ϩ mice, even on postnatal day 1 (P1) (Fig. 2A) , and the difference showed a considerable increase to approximately 1.4-fold by 40 weeks after birth ( Fig. 2A) . No difference was observed between PLCε ϩ/ϩ and PLCε ⌬X/ϩ mice ( Fig. 2A) . The PLCε ⌬X/⌬X hearts showed weight increases in both the left Weight ratios between the different heart compartment and the body. The heart was divided into the left ventricle (LV), right ventricle (RV), and atria, which were separately weighed. Nine mice of each genotype were examined at the indicated ages. *, P Ͻ 0.05; **, P Ͻ 0.01. and right ventricles, but not in the atria (Fig. 2C) . Similar results were obtained after five generations of backcrossing of this mutant mouse line with a wild-type C57BL/6 strain, indicating that the cardiac phenotype observed here is independent of the genetic background and is not due to artifacts that might have arisen from gene targeting (see Fig. S1 in the supplemental data). Analysis by M-mode echocardiography revealed that LVIDs at both end-diastole and end-systole of PLCε ⌬X/⌬X mice were greater than those of PLCε ϩ/ϩ mice at 8 or 20 weeks of age (Table 1 ). In contrast, interventricular septal thickness and left ventricular posterior wall thickness at end-diastole showed no significant difference (Table 1) . These results indicated that the observed heart enlargement was mainly due to ventricular dilation rather than hypertrophy. Consistent with this, histological analysis of azan-stained sections revealed no structural abnormality or fibrosis in the left ventricles of PLCε ⌬X/⌬X mice (data not shown).
Ventricular dilation of PLC
⌬X/⌬X mice is caused by regurgitation of the semilunar valves. Although some parameters of contractility, such as FS and mVcfc, appeared to be reduced in PLCε ⌬X/⌬X mice at 8 weeks of age (Table 1) , no obvious abnormality was found in pressure development, left ventricular end-diastolic pressure, and pressure relaxation at both 8 and 20 weeks of age ( Table 2 ), indicating that the systolic and diastolic functions of the PLCε ⌬X/⌬X hearts were almost normal. However, Doppler echocardiographic analysis revealed that the PLCε ⌬X/⌬X hearts clearly suffered from moderate to severe degrees of regurgitation of both the aortic valve ( Fig.  3A; see Fig. S2 in the supplementary data) and pulmonary valve (see Fig. S2 in the supplementary data) at the diastolic phase. The pulsed-wave Doppler also revealed that flow velocity across the PLCε ⌬X/⌬X aortic valve was abnormally fast (Fig.  3B) , indicating the presence of aortic stenosis. Transvalvular pressure gradients across the aortic, pulmonary, and mitral valves at the systolic phase were estimated from the flow velocities. Transvalvular pressure gradient across the aortic valve was around 20 mm Hg in PLCε ⌬X/⌬X mice (Table 3) , indicating a mild degree of aortic stenosis. This was also evidenced from the results of pressure measurement by a pullback of a catheter from the left ventricle to the aorta ( Fig. 3C; Table 2 ). Transvalvular pressure gradient across the pulmonary valve was also significantly high at 20 weeks (Table 3 ). These results indicated that PLCε ⌬X/⌬X mice suffered not only from regurgitation but also from stenosis at the semilunar valves. On the other hand, the mitral valves were almost unaffected in PLCε ⌬X/⌬X mice (Table 3) . Taken together, the cardiac dilation of PLCε ⌬X/⌬X mice was likely to be caused by chronic volume overload due mainly to semilunar valve regurgitation.
Thickening of the semilunar valve leaflets in PLC
⌬X/⌬X mice. Echocardiographic analysis revealed that the diameters of the semilunar valve orifices at the systolic phase were normal in PLCε ⌬X/⌬X mice (Table 3) . However, an anatomical examination of PLCε ⌬X/⌬X hearts of 20 weeks of age revealed that the sizes of the leaflets became uneven and the individual leaflet of the aortic valve exhibited marked thickening, although the aortic valve still maintained a three-leaved structure (Fig. 4A) . Some of the PLCε ⌬X/⌬X aortic valves at 40 weeks of age exhibited a bicuspid-like appearance due to commissural fusion (Fig. 4B ). This may suggest that the valve thickening aggravates an age-dependent deformation process. As observed with the heart weight increase, the valve malformation in PLCε ⌬X/⌬X mice was unaffected by five generations of backcross with C57BL/6 mice (see Fig. S3 in the supplemental data). We next analyzed which stage of the valve formation was disturbed in PLCε ⌬X/⌬X mice during embryogenesis because a sign of heart enlargement was observed in newborn mice (Fig. 2B) . On E15.5, the shape of the semilunar valves, as well as the septation of the aortic and pulmonary trunks and interventricles, of PLCε ⌬X/⌬X mice were indistinguishable from those of PLCε ϩ/ϩ mice ( Fig. 4C and data not shown), indicating that the early stages of valvular and septal formation, including endocardial cushion formation, proceeded normally without PLCε. However, the subsequent valvular remodeling step was obviously disturbed: while the immature aortic and pulmonary valves of PLCε ϩ/ϩ mice underwent remodeling to form slender leaflets on E16.5, those of PLCε ⌬X/⌬X mice still maintained thickened leaflets at E16.5 and later (Fig. 4 and data not shown). Moreover, both the aortic and pulmonary valves of PLCε ⌬X/⌬X mice underwent a massive increase in thickness on E16.5 (Fig. 4D) . The thickening of the aortic and pulmonary valves of PLCε ⌬X/⌬X mice appeared to be due to an increase in the number of cells, because PLCε deficiency did not alter cell size (Fig. 4E) . In the tricuspid and mitral valves, no apparent difference existed between PLCε ϩ/ϩ and The semilunar valve phenotypes of PLC ⌬X/⌬X mice are almost identical to those of mice deficient in HB-EGF or its receptor. PLCε is expressed all over the valve areas, both semilunar and atrioventricular, with high levels of expression at their margins (Fig. 5A and data not shown) . In addition, PLCε is also expressed in myocardium as reported previously (31) . The PLCε⌬X mutant protein is expressed in the PLCε ⌬X/⌬X heart in a similar fashion (Fig. 5A) . The semilunar valve malformation of PLCε ⌬X/⌬X mice showed a remarkable resemblance to the phenotypes of mice deficient in heparin-binding (HB) EGF-like growth factor (HB-EGF) or its receptor ErbB1, the EGF receptor (4, 11, 12) . The mice deficient in HB-EGF exhibit severe semilunar valve dysfunctions (11, 12) due to marked thickening of the valve leaflets, leading to early death of 60% of the newborn pups before weaning (12) . Considering that PLCε is activated by ErbB1-mediated signaling through activation of Ras or Rap (14, 23, 24 ), we anticipated a direct link between PLCε and HB-EGF signaling upon semilunar valvulogenesis. Thus, cells in the valve leaflets were examined for proliferation by the expression of proliferating cell nuclear antigen or Ki-67 antigen and for apoptosis by TdTmediated dUTP nick end labeling assay or by immunodetection of active caspase-3. However, we could not observe any significant difference in the number of cells undergoing proliferation or apoptosis between PLCε ϩ/ϩ and PLCε ⌬X/⌬X mice (data not shown). Because HB-EGF-deficient mice were reported to exhibit only a modest increase in proliferating cells compared to wild-type mice (12), it is not unexpected that we failed to observe a significant increase in PLCε ⌬X/⌬X mice, exhibiting a milder valve thickening.
Aberrant activation of Smad1/5/8 in the developing semilunar valve leaflets of PLC ⌬X/⌬X mice. Proliferation of the heart valve cells was reported to be positively controlled by bone morphogenetic protein signaling-mediated activation and negatively controlled by ErbB1-mediated suppression, of receptorregulated Smad, Smad1/5/8 (21) . Thus, we analyzed the level of the Smad1/5/8 activation by immunohistochemistry with an antibody specific to Smad1/5/8 phosphorylated at the C terminus. In the PLCε ϩ/ϩ pulmonary valves, cells positive for phospho-Smad1/5/8 preferentially resided at the margins of the developing valves on E13.5 through E14.5, and the frequency of the phospho-Smad1/5/8-positive cells did not increase significantly during this period (Fig. 5B and C) . On E15.5, the number of phospho-Smad1/5/8-positive cells increased in the marginal region of the pulmonary valves ( Fig. 5B and C) . In the PLCε ⌬X/⌬X pulmonary valves on E13.5, the distribution and frequency of the phospho-Smad1/5/8-positive cells were similar to those in the PLCε ϩ/ϩ counterparts ( Fig. 5B and C) . In striking contrast to the PLCε ϩ/ϩ pulmonary valves, the PLCε ⌬X/⌬X pulmonary valves exhibited an increase in the frequency of phospho-Smad1/5/8 positive cells on E14.5 ( Fig. 5B  and C) . The aortic valves also showed similar phenomena (data not shown). We next investigated ErbB1 activation in the developing semilunar valves. While no apparent difference existed in the extent of ErbB1 activation in PLCε ⌬X/⌬X pulmonary and aortic valves on E14.5 ( Fig. 5D and data not shown) , a significant increase in the number of activated ErbB1-harboring cells where Smad1/5/8 was simultaneously activated was observed ( Fig. 5D and E) . This suggested that activated ErbB1 failed to suppress Smad1/5/8 activation in the absence of PLCε. Taking these data together, it was concluded PLCε may play an important role in ErbB1-mediated negative regulation of the Smad1/5/8 activation at a late stage of semilunar valve development, specifically on E14.5.
DISCUSSION
We have shown here that loss of the enzymatic function of PLCε results in congenital malformation of the semilunar valves, which causes a moderate to severe degree of regurgitation with a mild degree of stenosis. Phenotypes affecting the heart are unprecedented in mice deficient in any other classes of PLCs (9) . The malformation apparently affects the semilunar valves but not the atrioventricular valves. Heart valve development consists of a number of complex processes. During mouse embryogenesis, premature hearts have a tubular structure consisting of endocardial and myocardial layers by E8.0; these layers are separated by an abundant extracellular matrix, cardiac jelly. After heart looping occurs at around E9.5, endocardial cells which reside in the atrioventricular canal and outflow tract undergo epithelium-to-mesenchyme transformation to form the atrioventricular and outflow tract cushions, respectively (13) . The epithelium-to-mesenchyme transformation begins to abate by E12.5 (17) , and a population of atrioventricular cushion cells subsequently develop into leaflets of the atrioventricular valves at the junction of the atria and ventricles. The outflow tract cushions fuse medially starting on E11.5 and, along with the assistance of neural crest-derived cells, separate the outflow tract into two distinct arteries, the aorta and pulmonary trunk (6) . The interventricular foramen closes by E14.5 (27) . Semilunar valves develop from the endocardial cushion cells at the distal ends of the proximal outflow tract segment through remodeling or cavitation of the cushion cells to form the definitive cup-shaped valvular leaflets along with their sinusal walls (28) . PLCε ⌬X/⌬X mice did not show any discernible defect in the development of the atrioventricular valves and the aorticopulmonary and interventricular septations. Also, the appearance of the developing semilunar valves of PLCε ⌬X/⌬X mice remained normal through E15.5; thickening first appeared on E16.5 (Fig. 4D ). These observations support a possible role of PLCε in remodeling the semilunar valves, particularly at the later stages of valvulogenesis, which is also consistent with our finding that PLCε ⌬X/⌬X mice showed aberrant activation of bone morphogenetic protein signaling specifically on the preceding day, E14.5 (Fig. 5B) .
The remarkable resemblance of the semilunar valve pheno- (Fig. 5B) . Activation of receptor-regulated Smad is known to induce hyperplasia of the cardiac valves (10) . The distribution of HB-EGF expression in the developing heart valves is confined to the margins of the valve leaflets (11, 12) , where we have observed the aberrant Smad1/5/8 activation (Fig. 5B) as well as the strong expression of PLCε (Fig. 5A) . These observations taken together suggest that PLCε mediates the HB-EGF-ErbB1-dependent negative regulation of Smad1/5/8 activation. Although the antagonistic effect of ErbB1 signaling on Smad activity has hitherto been thought to be mediated by the Ras-Raf-extracellular signal-regulated kinase pathway from the studies with cultured cell lines COS-1 and R-1B/L17 (16), we failed to observe any increase in extracellular signal-regulated kinase activity in the developing semilunar valves of PLCε ⌬X/⌬X mouse heart (data not shown). In HB-EGF Ϫ/Ϫ and ErbB1 Ϫ/Ϫ mice, cardiac dilation is much more severe than that of PLCε ⌬X/⌬X mice, leading to death during the embryonic or early perinatal period (4, 11, 12) . These mice exhibit a marked thickening of the both semilunar and atrioventricular valves. In contrast, Egfr wa2/wa2 mice, expressing an ErbB1 mutant (wa-2) with a residual (10 to 20% of normal) intrinsic tyrosine kinase activity, have a long life span, and only the semilunar valves show thickening (4, 12) as observed in PLCε ⌬X/⌬X mice. This difference in the nature of the affected valves may be ascribed to differential sensitivities in the strength of HB-EGF-ErbB1 signaling or to differential hemodynamic loads (26) during development between the semilunar and atrioventricular valves.
The relationship between PLCε and human heart diseases is not clear. The PLCε gene is located on human chromosome 10q23, where a candidate gene for a familial dilated cardiomyopathy affecting one family has been mapped (3). However, this familial dilated cardiomyopathy is reported to involve mitral valve prolapse in addition to a pure dilated cardiomyopathy (3), which seems to be quite different from the phenotype of PLCε ⌬X/⌬X mice. It is well known that valvular dysfunction is a common type of human congenital heart disease (2). More than half of patients with semilunar valvular disease Յ65 years of age have congenital bicuspid valves (19) . On the other hand, semilunar valvular disease maintaining the three-leaved (tricuspid) structure has been thought to be mostly acquired, with either rheumatic or age-dependent degenerative origin (19) . However, a number of such cases are thought to be congenital. Our present results imply that some of these cases, especially those showing thickened semilunar valve leaflets that do not affect the atrioventricular valves, may have an etiological connection with a defect of the PLCε gene. In addition, thickening and/or the uneven formation of the valve leaflets in PLCε ⌬X/⌬X mice may aggravate the age-dependent deformation process such as the commissural fusion (Fig. 4B) , which may give an acquired bicuspid-like appearance. Existing mouse models of aortic valve deformities caused by gene disruptions exhibit an absolutely short life span (4, 11, 12) . Therefore, it has been difficult to conduct detailed analyses of this phenotype. Since PLCε ⌬X/⌬X mice exhibit a long life span of at least 2 years, we believe that these mice will serve as a good animal model for deeper understanding of the pathophysiology of congenital valve malformations, such as the effects of exercise, stress, aging, or infectious diseases such as rheumatic fever.
